$6.86+0.29 (+4.41%)
Asana, Inc., together with its subsidiaries, operates a work management software platform for individuals, team leads, and executives in the United States and internationally.
Asana, Inc. in the Technology sector is trading at $6.86 with a market capitalization of $1.7B. Wall Street consensus targets $9.13 (13 analysts), implying a +33.2% move over the next 12 months. The stock is currently near its 52-week low of $5.38, remaining 27.9% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: MACD remains below its signal line. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $205.09M↓ | $205.57M↑ | $201.03M↑ | $196.94M↑ | $187.27M |
| Gross Profit | $179.68M↓ | $180.57M↑ | $178.73M↑ | $176.72M↑ | $168.04M |
| Operating Income | -$15.24M↑ | -$33.98M↑ | -$69.99M↓ | -$49.46M↓ | -$43.90M |
| Net Income | -$14.40M↑ | -$32.21M↑ | -$68.43M↓ | -$48.36M↓ | -$40.02M |
Asana, Inc., together with its subsidiaries, operates a work management software platform for individuals, team leads, and executives in the United States and internationally. The company provides work management products; Asana Work Graph, a proprie...
Asana (ASAN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
A number of stocks fell in the afternoon session after IBM issued a second-quarter earnings warning, suggesting that enterprise customers may be slashing software budgets to fund hardware purchases.
A number of stocks jumped in the afternoon session after investors appeared to rotate into oversold enterprise software names amid profit taking in chip stocks.
Asana Partners and Norges Bank launched a $500M retail venture targeting grocery-anchored centers in high-growth US markets.
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are usually cheap for a reason — five cents for a piece of fruit may seem like a great deal until you find out it’s rotten.